Memory Beta, non-canon Star Trek Wiki

A friendly reminder regarding spoilers! As always, the expanded Trek universe is in a period of major upheaval with the continuations of Strange New Worlds and Prodigy, the advent of new eras in gaming with the Star Trek Adventures RPG and Star Trek Online, as well as other eventful releases such as Section 31, the ongoing IDW Star Trek comic and spin-off Star Trek: Defiant. Therefore, please be courteous to other users who may not be aware of current developments by using the {{spoiler}}, {{spoilers}} OR {{majorspoiler}} tags when adding new information from sources less than six months old (even if it is minor info). Also, please do not include details in the summary bar when editing pages and do not anticipate making additions relating to sources not yet in release. THANK YOU

READ MORE

Memory Beta, non-canon Star Trek Wiki

Reserpine was a type of anti-anxiety, light sedative drug available to the Federation in the 24th century.

History and specifics[]

It reduced the flow of monoamine oxidase in synaptic pathways. Unlike other compounds producing that result, including ammonium compounds, ergot alkaloids, guanethidine, nicotine, pranolol, and thymoxamine, reserpine was gentlest. However, as a side effect it could cause Parkinsonism.

In 2371, reserpine was injected into the bioneural gel packs aboard USS Voyager in an attempt to stop systems failures. Kes chose it from The Doctor's list of available options, though his programming was affected by the treatment, because his memories were stored in the gel packs. System functions improved, but were slowed by the sedative affect. (VOY novel: Violations)

Monoamine oxidase inhibitors are a real-world class of anti-anxiety medicines. Developed in the 1950s, reserpine is used in the 21st century to treat hypertension. At higher doses, Parkinsonism is a real-world adverse effect.

Appendices[]

References[]

External links[]